- Home
- AVIR vs BCML Comparison
AVIR vs BCML Comparison
Compare AVIR & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- BCML
- Stock Information
- Founded
- AVIR 2012
- BCML 2004
- Country
- AVIR United States
- BCML United States
- Employees
- AVIR N/A
- BCML N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- BCML Major Banks
- Sector
- AVIR Health Care
- BCML Finance
- Exchange
- AVIR Nasdaq
- BCML Nasdaq
- Market Cap
- AVIR 290.4M
- BCML 325.0M
- IPO Year
- AVIR 2020
- BCML N/A
- Fundamental
- Price
- AVIR $3.14
- BCML $28.00
- Analyst Decision
- AVIR Hold
- BCML Strong Buy
- Analyst Count
- AVIR 1
- BCML 1
- Target Price
- AVIR $6.00
- BCML $32.00
- AVG Volume (30 Days)
- AVIR 399.6K
- BCML 16.8K
- Earning Date
- AVIR 11-06-2025
- BCML 10-17-2025
- Dividend Yield
- AVIR N/A
- BCML 2.84%
- EPS Growth
- AVIR N/A
- BCML 2.85
- EPS
- AVIR N/A
- BCML 2.18
- Revenue
- AVIR N/A
- BCML $96,577,000.00
- Revenue This Year
- AVIR N/A
- BCML $3.39
- Revenue Next Year
- AVIR N/A
- BCML $8.03
- P/E Ratio
- AVIR N/A
- BCML $12.91
- Revenue Growth
- AVIR N/A
- BCML N/A
- 52 Week Low
- AVIR $2.46
- BCML $22.22
- 52 Week High
- AVIR $4.02
- BCML $30.96
- Technical
- Relative Strength Index (RSI)
- AVIR 52.91
- BCML 37.19
- Support Level
- AVIR $2.78
- BCML $27.79
- Resistance Level
- AVIR $2.94
- BCML $28.36
- Average True Range (ATR)
- AVIR 0.10
- BCML 0.58
- MACD
- AVIR 0.04
- BCML -0.18
- Stochastic Oscillator
- AVIR 90.79
- BCML 14.16
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.